跳至主要内容
临床试验/NCT04006444
NCT04006444已完成不适用

Characterization of the Iatrogenic Drug Risk in Elderly Patients With Chronic Pain Who Consult the Pain Assessment and Treatment Centre at the Nimes University Hospital

Centre Hospitalier Universitaire de Nīmes1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Evolution of the ADE Geriatric risk score

研究概览

简要总结

Chronic pain may be an additional risk factor for drug iatrogeny due to its management and also drug non-compliance in the geriatric population.

it seems interesting to carry out an inventory of the iatrogenic risk before and after the consultation at the pain centre to enable us to identify the patients most at risk. This study would make it possible to characterize elderly patients with chronic pain, in order to consider, in a future study, setting up a pharmaceutical consultation.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
65 Years 至 100 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must be affiliated or beneficiary of a health insurance
  • Patient ≥ 65 years old
  • Having an outpatient consultation at the pain centre of the Nîmes University hospital of for chronic pain
  • Available for pharmaceutical consultation about 30 minutes

排除标准

  • It is impossible to give information
  • The patient objects to participating in this study

结局指标

主要结局

Evolution of the ADE Geriatric risk score

时间窗: 2018

The score is calculated on 10 points based on 3 criteria : number of drugs prescribed, prescription of neuroleptics and the initiation of an anticoagulant prescription less than 3 months old. It classifies patients into 3 risk categories: a low risk level for a score of 0 to 1 point, a medium risk level for a score of 2 to 5 points and a high risk level for a score of 6 to 10 points.

次要结局

  • rate of patients with a low, medium or high risk level calculated by ADE Geriatric risk score according to the type of pain(2018)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验